Unliganded estrogen receptor-α activates transcription of the mammary gland Na+/I- symporter gene

Biochemical and Biophysical Research Communications

Volumn 345, Issue 4, 2006, Pages 1487-1496

  Alotaibi, Hani ^a   Yaman, Elif Çankaya ^a   Demirpençe, Ediz ^b   Tazebay, Uygar H ^a  

^a BILKENT UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Estrogen receptor; Iodide transport; Mammary gland; NIS

Indexed keywords

ESTROGEN RECEPTOR ALPHA; RETINOIC ACID; SODIUM IODIDE SYMPORTER;

ARTICLE; BREAST CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAMMARY GLAND; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTORS, RETINOIC ACID; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYMPORTERS; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 33744519038     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.049     Document Type: Article

References (35)

1. Tazebay U.H., Wapnir I.L., Levy O., Dohan O., Zuckier L.S., Zhao Q.H., Deng H.F., Amenta P.S., Fineberg S., Pestell R.G., and Carrasco N. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med. 6 (2000) 871-878
2. Stubbe P., Schulte F.J., and Heidemann P. Iodine deficiency and brain development. Bibl. Nutr. Dieta. (1986) 206-208
3. Kogai T., Schultz J.J., Johnson L.S., Huang M., and Brent G.A. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc. Natl. Acad. Sci. USA 97 (2000) 8519-8524
4. Schmutzler C., and Kohrle J. Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 10 (2000) 393-406
5. Tanosaki S., Ikezoe T., Heaney A., Said J.W., Dan K., Akashi M., and Koeffler H.P. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Breast Cancer Res. Treat. 79 (2003) 335-345
6. Dentice M., Luongo C., Elefante A., Romino R., Ambrosio R., Vitale M., Rossi G., Fenzi G., and Salvatore D. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells. Mol. Cell. Biol. 24 (2004) 7863-7877
7. Métivier R., Penot G., Carmouche R.P., Hubner M.R., Reid G., Denger S., Manu D., Brand H., Kos M., Benes V., and Gannon F. Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. EMBO J. 23 (2004) 3653-3666
8. Jakowlew S.B., Breathnach R., Jeltsch J.M., Masiakowski P., and Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res. 12 (1984) 2861-2878
9. Demirpence E., Semlali A., Oliva J., Balaguer P., Badia E., Duchesne M.J., Nicolas J.C., and Pons M. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen. Cancer Res. 62 (2002) 6519-6528
10. Ortmann O., Sturm R., Knuppen R., and Emons G. Weak estrogenic activity of phenol red in the pituitary gonadotroph: re-evaluation of estrogen and antiestrogen effects. J. Steroid Biochem. 35 (1990) 17-22
11. Welshons W.V., Wolf M.F., Murphy C.S., and Jordan V.C. Estrogenic activity of phenol red. Mol. Cell. Endocrinol. 57 (1988) 169-178
12. Elgort M.G., Zou A., Marschke K.B., and Allegretto E.A. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence. Mol. Endocrinol. 10 (1996) 477-487
13. Wapnir I.L., Goris M., Yudd A., Dohan O., Adelman D., Nowels K., and Carrasco N. The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin. Cancer Res. 10 (2004) 4294-4302
14. Furlanetto T.W., Nguyen L.Q., and Jameson J.L. Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140 (1999) 5705-5711
15. Glinoer D. The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Pract. Res. Clin. Endocrinol. Metab. 18 (2004) 133-152
16. Glinoer D. Pregnancy and iodine. Thyroid 11 (2001) 471-481
17. Kerley J.S., Olsen S.L., Freemantle S.J., and Spinella M.J. Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem. Biophys. Res. Commun. 285 (2001) 969-975
18. Merot Y., Metivier R., Penot G., Manu D., Saligaut C., Gannon F., Pakdel F., Kah O., and Flouriot G. The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor alpha transcriptional activity depends upon the differentiation stage of the cell. J. Biol. Chem. 279 (2004) 26184-26191
19. Métivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763
20. Perissi V., and Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 6 (2005) 542-554
21. Delage-Mourroux R., Martini P.G., Choi I., Kraichely D.M., Hoeksema J., and Katzenellenbogen B.S. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J. Biol. Chem. 275 (2000) 35848-35856
22. Bajic V.B., Tan S.L., Chong A., Tang S., Strom A., Gustafsson J.A., Lin C.Y., and Liu E.T. Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res. 31 (2003) 3605-3607
23. Bourdeau V., Deschenes J., Metivier R., Nagai Y., Nguyen D., Bretschneider N., Gannon F., White J.H., and Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 18 (2004) 1411-1427
24. Mader S., Leroy P., Chen J.Y., and Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J. Biol. Chem. 268 (1993) 591-600
25. Cho J.Y., Leveille R., Kao R., Rousset B., Parlow A.F., Burak Jr. W.E., Mazzaferri E.L., and Jhiang S.M. Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J. Clin. Endocrinol. Metab. 85 (2000) 2936-2943
26. Dohan O., De la Vieja A., and Carrasco N. Hydrocortisone and purinergic signaling stimulate NIS-mediated iodide transport in breast cancer cells. Mol. Endocrinol. (2006)
27. Kogai T., Kanamoto Y., Che L.H., Taki K., Moatamed F., Schultz J.J., and Brent G.A. Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models. Cancer Res. 64 (2004) 415-422
28. Kogai T., Kanamoto Y., Li A.I., Che L.H., Ohashi E., Taki K., Chandraratna R.A., Saito T., and Brent G.A. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. Endocrinology 146 (2005) 3059-3069
29. Rillema J.A., Williams C.H., Moulden J., and Golden K.L. Effect of insulin on iodide uptake in mouse mammary gland explants. Exp. Biol. Med. (Maywood) 227 (2002) 32-35
30. Rillema J.A., Yu T.X., and Jhiang S.M. Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E769-E772
31. Schmutzler C., Schmitt T.L., Glaser F., Loos U., and Kohrle J. The promoter of the human sodium/iodide-symporter gene responds to retinoic acid. Mol. Cell. Endocrinol. 189 (2002) 145-155
32. Dadachova E., and Carrasco N. The Na/I symporter (NIS): imaging and therapeutic applications. Semin. Nucl. Med. 34 (2004) 23-31
33. Simon D., Korber C., Krausch M., Segering J., Groth P., Gorges R., Grunwald F., Muller-Gartner H.W., Schmutzler C., Kohrle J., Roher H.D., and Reiners C. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 775-782
34. Grunwald F., Menzel C., Bender H., Palmedo H., Otte R., Fimmers R., Risse J., and Biersack H.J. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J. Nucl. Med. 39 (1998) 1903-1906
35. Koerber C., Schmutzler C., Rendl J., Koehrle J., Griesser H., Simon D., and Reiners C. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid. Clin. Nucl. Med. 24 (1999) 849-851